3 NRI-Led Companies Make TIME100 Most Influential Companies of 2025

Los Angeles/ July 24, 2025
NRIpress.club/Ramesh/ A.Gary Singh

3 NRI CEOs companies led have earned spots on the TIME100 Most Influential Companies of 2025, highlighting the global impact of NRI leadership in healthcare and biotechnology.

Qure.ai, led by Prashant Warier, is revolutionizing global diagnostics with AI-powered tools that interpret medical images like X-rays and CT scans, helping detect diseases such as lung cancer and tuberculosis, especially in regions with limited medical specialists. Qure.ai’s deep-learning algorithms, now deployed in over 100 countries, have earned 18 FDA clearances, the highest for lung cancer AI in the U.S.

CRISPR Therapeutics, under CEO Sam Kulkarni, is driving gene-editing breakthroughs. After winning FDA approval for a CRISPR-based treatment for sickle cell disease and beta thalassemia, the company is expanding its focus to more common conditions like high cholesterol and lupus, aiming to make cutting-edge gene therapies more accessible and affordable within this decade.

Vertex Pharmaceuticals, led by Dr. Reshma Kewalramani, is a front-runner in biotech innovation. Vertex co-developed Casgevy, the first CRISPR treatment approved by the FDA, and continues its mission of “one and done” curative medicines. Vertex’s pipeline includes advanced cell-based therapies for type 1 diabetes and new treatments for chronic kidney disease, reinforcing its commitment to transformative, non-duplicative drug design.